Thus, TMEM63C was overexpressed in T-47D and MCF-7 cells, and it was found that the viability and clone formation ability were significantly improved, suggesting that TMEM63C may be a potential target in breast cancer treatment. The gene discussed is TMEM63C; the disease is breast cancer.